SAS Blogs

Podcasts

• The Health Pulse | Part of the Analytics Exchange: Podcasts From SAS
• AI Hungary | When Healthcare Reaches for an Algorithmic Helping Hand

Articles & Reports

• PIONEER | SAS deploys SAS Viya in the central PIONEER Big Data Platform for Prostate Cancer
• ITProPortal | The Modernization of Health and Pharma Analytics in a Post-Covid World
• Trends Top Blog | Top ICT – Software cruciaal in strijd tegen COVID-19
• Hospital and Healthcare | New Horizons for Health and Life Sciences Data
• CMSWire | How Data Analytics Are Gaining Ground During COVID-19
• The Economist | Resilience in Life Sciences: Keeping Up With the New Pace of Change
• Applied Clinical Trials | The Impact of AI, Precision Medicine, Mobile Health Technology on Streamlined Clinical Trials
• ITProPortal | The Tricky Task of Using Data to Tackle COVID-19
• Computerworld | Data, Analysis and COVID-19
• Gadget | Big Data Used to Combat COVID-19
• ITWeb | Visual Analytics Can Help Combat COVID-19
• Saudi Gazette | How AI Could Help Tackle the Coronavirus Outbreak

Live & Online Events

• COVID-19 Modeling Webinar Series | Webinar 10: Saving Lives During a Global Pandemic Through Medical Resource Optimization
• On-Demand Webinar | Using Analytics to Uncover Hidden Insights in the COVID-19 Outbreak

Mark's Bio

Mark Lambrecht, PhD, Director of the Global Health and Life Sciences Practice, joined SAS in 2005. He leads a senior team focused on the health care and life sciences (HLS) industries, and is responsible for the global health care and life sciences market strategy for SAS.

Mark’s team is taking new SAS solutions for HLS to market and constantly looking for innovation opportunities by identifying customer needs and supporting those needs with repeatable offerings. He speaks regularly at conferences and to customers at all levels in an industry that deals with patient data and is, therefore, strongly regulated. Mark’s interests include the impact of observational patient data, fostering data standards and enabling the industry to share and reuse patient data to find new cures and to benefit all of humanity.

Prior to joining SAS, Mark worked in the pharmaceutical industry. He studied at the KU Leuven in Belgium and at Stanford University in the US, where he worked as a bioinformatics scientist, specializing as a data scientist for high volumes of biological and genomics data using diverse technologies and approaches.

He holds a master’s degree and PhD in bioscience engineering from the University of Leuven, Belgium.